Menu Search
Equities

Biohit Oyj

BIOBVh:EBT

Biohit Oyj

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Biohit Oyj grew revenues 19.40% from 10.95m to 13.08m while net income improved 207.99% from 601.00k to 1.85m.
Gross margin64.73%
Net profit margin14.16%
Operating margin13.96%
Return on assets15.47%
Return on equity21.93%
Return on investment20.55%
More ▼

Cash flow in EURView more

In 2023, Biohit Oyj increased its cash reserves by 42.65%, or 905.00k. The company earned 902.00k from its operations for a Cash Flow Margin of 6.90%. In addition the company generated 192.00k cash from investing, though they paid out 199.00k more in financing than they received.
Cash flow per share0.1444
Price/Cash flow per share11.73
Book value per share0.6237
Tangible book value per share0.6116
More ▼

Balance sheet in EURView more

Biohit Oyj has a Debt to Total Capital ratio of 6.93%, a lower figure than the previous year's 9.20%.
Current ratio3.87
Quick ratio3.58
Total debt/total equity0.0745
Total debt/total capital0.0693
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.